Metabolic causes of liver disease among adults living with HIV from low‐ and middle‐income countries: a cross‐sectional study
Journal of the International AIDS Society · 2024-04 · 27 (4)
DOI: 10.1002/jia2.26238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the International AIDS Society, online erschienen am 02.04.2024. Verfasst von Marie Kerbie Plaisy und 22 weiteren Autor:innen. Beteiligte Einrichtung: University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EM…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, HIV Infections, Dyslipidemias. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIA NIH HHS.
Abstract (Originalsprache)
Introduction
Liver disease is a leading cause of morbidity and mortality among persons living with HIV (PLHIV). While chronic viral hepatitis has been extensively studied in low‐ and middle‐income countries (LMICs), there is limited information about the burden of metabolic disorders on liver disease in PLHIV.
Methods
We conducted a cross‐sectional analysis of baseline data collected between October 2020 and July 2022 from the IeDEA‐Sentinel Research Network, a prospective cohort enrolling PLHIV ≥40 years on antiretroviral treatment (ART) for ≥6 months from eight clinics in Asia, Americas, and central, East, southern and West Africa. Clinical assessments, laboratory testing on fasting blood samples and liver stiffness measurement (LSM)/controlled attenuation parameter (CAP) by vibration‐controlled transient elastography were performed. Multivariable logistic regression models assessed factors associated with liver fibrosis (LSM ≥7.1 kPa) and steatosis (CAP ≥248 dB/m). Population attributable fraction (PAF) of each variable associated with significant liver fibrosis was estimated using Levin's formula.
Results
Overall, 2120 PLHIV (56% female, median age 50 [interquartile range: 45−56] years) were included. The prevalence of obesity was 19%, 12% had type 2 diabetes mellitus (T2DM), 29% had hypertension and 53% had dyslipidaemia. The overall prevalence of liver fibrosis and steatosis was 7.6% (95% confidence interval [CI] 6.1−8.4) and 28.4% (95% CI 26.5−30.7), respectively, with regional variability. Male sex at birth (odds ratio [OR] 1.62, CI 1.10−2.40), overweight/obesity (OR = 2.50, 95% CI 1.69−3.75), T2DM (OR 2.26, 95% CI 1.46−3.47) and prolonged exposure to didanosine (OR 3.13, 95% CI 1.46−6.49) were associated with liver fibrosis. Overweight/obesity and T2DM accounted for 42% and 11% of the PAF for liver fibrosis, while HBsAg and anti‐HCV accounted for 3% and 1%, respectively. Factors associated with steatosis included overweight/obesity (OR 4.25, 95% CI 3.29−5.51), T2DM (OR 2.06, 95% CI 1.47−2.88), prolonged exposure to stavudine (OR 1.69, 95% CI 1.27−2.26) and dyslipidaemia (OR 1.68, 95% CI 1.31−2.16).
Conclusions
Metabolic disorders were significant risk factors for liver disease among PLHIV in LMICs. Early recognition of metabolic disorders risk factors might be helpful to guide clinical and lifestyle interventions. Further prospective studies are needed to determine the causative natures of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France.
- Blood Bank Medical Centre, the HIV care clinic of the National Blood Transfusion Centre, Abidjan, Côte d'Ivoire.
- Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
- Research for Development (RD Rwanda) and Rwanda Military Hospital, Kigali, Rwanda.
- Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
- TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand.
ORCID-Profile: Marie Kerbie Plaisy, Albert K Minga, Gad Murenzi, Alvaro Lopez, Mark H Kuniholm
Förderung
- NIAID NIH HHS
- NIA NIH HHS
Zitieren
APA
Plaisy, M. K., Minga, A. K., Wandeler, G., Murenzi, G., Samala, N., Ross, J., Lopez, A., Mensah, E., de Waal, R., Kuniholm, M. H., Diero, L., Salvi, S., Moreira, R., Attia, A., Mandiriri, A., Shumbusho, F., Goodrich, S., Rupasinghe, D., Alarcon, P., …, & Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS (2024). Metabolic causes of liver disease among adults living with HIV from low‐ and middle‐income countries: a cross‐sectional study. Journal of the International AIDS Society, 27(4). https://doi.org/10.1002/jia2.26238
Vancouver
Plaisy MK, Minga AK, Wandeler G, Murenzi G, Samala N, Ross J, et al. Metabolic causes of liver disease among adults living with HIV from low‐ and middle‐income countries: a cross‐sectional study. Journal of the International AIDS Society. 2024;27(4). doi:10.1002/jia2.26238
BibTeX
@article{Plaisy2024,
author = {Plaisy, Marie Kerbie and Minga, Albert K and Wandeler, Gilles and Murenzi, Gad and Samala, Niharika and Ross, Jeremy and Lopez, Alvaro and Mensah, Ephrem and de Waal, Renée and Kuniholm, Mark H and Diero, Lameck and Salvi, Sonali and Moreira, Rodrigo and Attia, Alain and Mandiriri, Ardele and Shumbusho, Fabienne and Goodrich, Suzanne and Rupasinghe, Dhanushi and Alarcon, Paola and Maruri, Fernanda and Perrazo, Hugo and Jaquet, Antoine and Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS, Sentinel Research Network of the International epidemiology Databases to Evaluate AIDS},
title = {Metabolic causes of liver disease among adults living with HIV from low‐ and middle‐income countries: a cross‐sectional study},
journal = {Journal of the International AIDS Society},
year = {2024},
volume = {27},
number = {4},
doi = {10.1002/jia2.26238}
}
EUVIMED